1
H-36731: Finasteride in Management of Elevated Red Blood Cells
Condition(s):ERYTHROCYTOSISLast Updated:December 16, 2019Withdrawn
Finasteride: 84 Clinical Trials, Page 1 of 9
Hide Studies Not Open or Pending
2
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
Condition(s):Benign Prostatic Hyperplasia; Prostate Hyperplasia; Prostate Disease; Prostate Hypertrophy; Prostate Pain; Lower Urinary Tract Symptoms; Urinary Obstruction; Urinary Tract DiseaseLast Updated:March 18, 2021Recruiting
3
Bioequivalence Study of Dr. Reddy’s Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition
Condition(s):HealthyLast Updated:July 12, 2010Completed
4
Bioequivalence Study of Dr.Reddy’s Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition
Condition(s):HealthyLast Updated:May 28, 2010Completed
5
Finasteride for Chronic Central Serous Chorioretinopathy
Condition(s):Retinal DiseaseLast Updated:December 4, 2014Terminated
6
Bioequivalence Study of Finasteride 5 mg Tablet Formulations Under Fasting Conditions
Condition(s):HealthyLast Updated:December 21, 2010Completed
7
Bioequivalence Study of Two Finasteride 5 mg Tablet Formulations Under Non-Fasting Conditions
Condition(s):HealthyLast Updated:December 21, 2010Completed
8
A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance
Condition(s):Detectable Prostate NodulesLast Updated:March 22, 2017Withdrawn
9
3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer
Condition(s):Prostate CancerLast Updated:October 6, 2017Completed
10
Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
Condition(s):Retinal DiseaseLast Updated:November 20, 2013Completed